These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 23817325)
21. Network Pharmacology-Based Approaches of Baek SY; Lee EH; Oh TW; Do HJ; Kim KY; Park KI; Kim YW Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32178308 [No Abstract] [Full Text] [Related]
22. To pee or not to pee: ammonia hypothesis of hepatic encephalopathy revisited. Mpabanzi L; Olde Damink SW; van de Poll MC; Soeters PB; Jalan R; Dejong CH Eur J Gastroenterol Hepatol; 2011 Jun; 23(6):449-54. PubMed ID: 21537121 [TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory effects of etanercept (TNFR:Fc) and its use in a patient with Crohn's disease. Srivastava MD Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):125-41. PubMed ID: 11458980 [TBL] [Abstract][Full Text] [Related]
25. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Wright G; Noiret L; Olde Damink SW; Jalan R Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233 [TBL] [Abstract][Full Text] [Related]
26. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury. Tukov FF; Luyendyk JP; Ganey PE; Roth RA Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507 [TBL] [Abstract][Full Text] [Related]
27. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Feldmann M; Maini RN Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034 [TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus (HBV) reactivation in patients receiving tumor necrosis factor (TNF)-targeted therapy: analysis of 257 cases. Pérez-Alvarez R; Díaz-Lagares C; García-Hernández F; Lopez-Roses L; Brito-Zerón P; Pérez-de-Lis M; Retamozo S; Bové A; Bosch X; Sanchez-Tapias JM; Forns X; Ramos-Casals M; Medicine (Baltimore); 2011 Nov; 90(6):359-371. PubMed ID: 22033451 [TBL] [Abstract][Full Text] [Related]
36. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure. Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263 [TBL] [Abstract][Full Text] [Related]
37. Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy. Luo M; Liu H; Hu SJ; Bai FH Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):665-73. PubMed ID: 26216028 [TBL] [Abstract][Full Text] [Related]
38. Etanercept in psoriasis treatment. Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989 [TBL] [Abstract][Full Text] [Related]
39. Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines. Greenberg P Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii41-2. PubMed ID: 11890651 [TBL] [Abstract][Full Text] [Related]
40. Pathophysiology of Hepatic Encephalopathy. Jaffe A; Lim JK; Jakab SS Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]